Acuta Capital Partners’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-90,832
| Closed | -$30K | – | 34 |
|
|
2025
Q4 | $30K | Hold |
90,832
| – | – | 0.02% | 30 |
|
|
2025
Q3 | $18.4K | Hold |
90,832
| – | – | 0.02% | 28 |
|
|
2025
Q2 | $24.5K | Hold |
90,832
| – | – | 0.03% | 28 |
|
|
2025
Q1 | $17.5K | Hold |
90,832
| – | – | 0.02% | 33 |
|
|
2024
Q4 | $20.9K | Hold |
90,832
| – | – | 0.02% | 39 |
|
|
2024
Q3 | $8.89K | Hold |
90,832
| – | – | 0.01% | 41 |
|
|
2024
Q2 | $14.5K | Hold |
90,832
| – | – | 0.01% | 33 |
|
|
2024
Q1 | $27.5K | Hold |
90,832
| – | – | 0.02% | 33 |
|
|
2023
Q4 | $5.45K | Hold |
90,832
| – | – | ﹤0.01% | 39 |
|
|
2023
Q3 | $9.08K | Hold |
90,832
| – | – | 0.01% | 46 |
|
|
2023
Q2 | $15K | Hold |
90,832
| – | – | 0.01% | 35 |
|
|
2023
Q1 | $10.9K | Hold |
90,832
| – | – | 0.01% | 35 |
|
|
2022
Q4 | $13.1K | Hold |
90,832
| – | – | 0.01% | 34 |
|
|
2022
Q3 | $15K | Hold |
90,832
| – | – | 0.01% | 46 |
|
|
2022
Q2 | $25K | Buy |
+90,832
| New | +$58.4K | 0.01% | 43 |
|
|
2021
Q4 | – | Sell |
-90,832
| Closed | -$242K | – | 47 |
|
|
2021
Q3 | $242K | Hold |
90,832
| – | – | 0.09% | 47 |
|
|
2021
Q2 | $236K | Sell |
90,832
-2,500
| -3% | -$8.15K | 0.09% | 38 |
|
|
2021
Q1 | $249K | Buy |
+93,332
| New | +$270K | 0.09% | 46 |
|
Acuta Capital Partners's NUVB.WS Position: Q1 2026 in Review
Acuta Capital Partners sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 90,832 shares — an estimated $30K sold.
Acuta Capital Partners first reported a position in NUVB.WS in Q1 2021 and held it in 18 quarters. The position peaked at $249K in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- Acuta Capital Partners reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- Acuta Capital Partners sold 90,832 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $30K.
- Acuta Capital Partners first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 18 quarters.
- Acuta Capital Partners's Nuvation Bio Inc Warrants position peaked at $249K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on Acuta Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.